+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Anavip Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • PDF Icon

    Report

  • 175 Pages
  • April 2025
  • Region: Global
  • The Business Research Company
  • ID: 6073901
This Anavip market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

Market growth during the historic period can be attributed to the prevalence of snakebites, the regional distribution of venomous snakes, increased public awareness, improvements in healthcare infrastructure, and regulatory approvals for antivenoms.

The projected growth during the forecast period can be attributed to the rising demand from the military and outdoor industries, government initiatives, increased investments in research and development, expanded market access, and patient access programs. Key trends expected during this period include personalized treatment approaches, growing adoption in emerging markets, the rise of combination therapies, an emphasis on cost-effectiveness, regulatory changes, and ongoing product innovation.

The rising prevalence of snakebites is expected to propel the growth of the anavip market moving forward. Snakebites, particularly from venomous snakes, can lead to envenomation, which may result in severe medical complications or death if not treated promptly. Snakebites are more common in rural areas, agricultural settings, and regions near venomous snake habitats, particularly in tropical and subtropical climates. Anavip is a key treatment for snakebite victims, as it neutralizes venom toxins and alleviates symptoms like swelling, tissue damage, and systemic effects. According to the World Health Organization (WHO), approximately 5.4 million people are bitten by snakes each year, resulting in 1.8 to 2.7 million cases of envenoming and between 81,410 and 137,880 deaths annually. The prevalence of snakebites is thus driving the demand for anavip.

The rising rural populations are expected to contribute to the growth of the anavip market. Rural populations are increasing in some regions due to natural growth and efforts to improve rural infrastructure and economic opportunities. In rural areas, snakebite incidents are more frequent due to agricultural work and outdoor activities. Anavip plays a crucial role in treating snakebite envenomation in these areas, where access to medical care can be limited. For instance, in April 2024, the Australian Institute of Health and Welfare reported that approximately 7 million people (28% of Australia’s population) reside in rural and remote areas, where snakebites are more common. Therefore, the growing rural population is driving the demand for anavip.

Rising healthcare expenditure is factor propelling the growth of the anavip market. Increased healthcare spending reflects greater investment in medical services, infrastructure, and specialized treatments. As healthcare expenditures rise, there is a corresponding increase in the demand for treatments like Anavip that are used in snakebite management, which requires specialized production and distribution. For example, in November 2024, Eurostat reported that Belgium's healthcare expenditure increased from 1.59 billion euros in 2021 to 1.65 billion euros in 2022. As healthcare expenditure continues to rise globally, so too does the demand for specialized treatments such as anavip, which supports the growth of the market.

Key player operating in the anavip market is Rare Disease Therapeutics Inc.

North America was the largest region in the anavip market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the Anavip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Anavip (crotalidae immune F(ab’)2 (equine)) is an antivenom used to treat envenomation from North American rattlesnake bites. It works by neutralizing venom toxins to reduce swelling, tissue damage, and systemic effects. Derived from purified antibodies obtained from horses, Anavip offers an extended half-life, requiring fewer doses compared to other antivenoms.

The main types of anavip antivenom include neurotoxic, cytotoxic, hemotoxic, and cardiotoxic. Neurotoxic agents refer to substances that damage the nervous system, including the brain, spinal cord, or peripheral nerves. These toxins can disrupt nerve signaling, causing symptoms like paralysis, seizures, or respiratory failure. Anavip is distributed through various channels, including direct sales and distributors, and is used by hospitals and clinics for the treatment of rattlesnake bites.

The anavip market research report is one of a series of new reports that provides anavip market statistics, including the anavip industry's global market size, regional shares, competitors with an anavip market share, detailed anavip market segments, market trends and opportunities, and any further data you may need to thrive in the anavip industry. This anavip market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The anavip market consists of sales of Anavip antivenom, and antivenom administration kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Anavip Market Characteristics
3. Anavip Market Biologic Drug Characteristics
3.1. Molecule Type
3.2. Route of Administration (ROA)
3.3. Mechanism of Action (MOA)
3.4. Safety and Efficacy
4. Anavip Market Trends and Strategies5. Anavip Market - Macro Economic Scenario Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market
6. Global Anavip Growth Analysis and Strategic Analysis Framework
6.1. Global Anavip PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.2. Analysis of End Use Industries
6.3. Global Anavip Market Growth Rate Analysis
6.4. Global Anavip Historic Market Size and Growth, 2019-2024, Value ($ Billion)
6.5. Global Anavip Forecast Market Size and Growth, 2024-2029, 2034F, Value ($ Billion)
6.6. Global Anavip Total Addressable Market (TAM)
7. Global Anavip Market Pricing Analysis & Forecasts
8. Anavip Market Segmentation
8.1. Global Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neurotoxic
  • Cytotoxic
  • Hemotoxic
  • Cardiotoxic
8.2. Global Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Sales
  • Distributors
8.3. Global Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
9. Global Anavip Market Epidemiology of Clinical Indications
9.1. Drug Side Effects
9.2. Incidence and Prevalence of Clinical Indications
10. Anavip Market Regional and Country Analysis
10.1. Global Anavip Market, Split by Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. Global Anavip Market, Split by Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Asia-Pacific Anavip Market
11.1. Asia-Pacific Anavip Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Asia-Pacific Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Asia-Pacific Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. China Anavip Market
12.1. China Anavip Market Overview
12.2. China Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.3. China Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
12.4. China Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
13. India Anavip Market
13.1. India Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. India Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. India Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. Japan Anavip Market
14.1. Japan Anavip Market Overview
14.2. Japan Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. Japan Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. Japan Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Australia Anavip Market
15.1. Australia Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.2. Australia Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Australia Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. South Korea Anavip Market
16.1. South Korea Anavip Market Overview
16.2. South Korea Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. South Korea Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.4. South Korea Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Western Europe Anavip Market
17.1. Western Europe Anavip Market Overview
17.2. Western Europe Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Western Europe Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.4. Western Europe Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. UK Anavip Market
18.1. UK Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. UK Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. UK Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Germany Anavip Market
19.1. Germany Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Germany Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Germany Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. France Anavip Market
20.1. France Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. France Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. France Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Anavip Market
21.1. Eastern Europe Anavip Market Overview
21.2. Eastern Europe Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. North America Anavip Market
22.1. North America Anavip Market Overview
22.2. North America Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. North America Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.4. North America Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. USA Anavip Market
23.1. USA Anavip Market Overview
23.2. USA Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. USA Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. USA Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. Canada Anavip Market
24.1. Canada Anavip Market Overview
24.2. Canada Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. Canada Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. Canada Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. South America Anavip Market
25.1. South America Anavip Market Overview
25.2. South America Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. South America Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. South America Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. Middle East Anavip Market
26.1. Middle East Anavip Market Overview
26.2. Middle East Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. Middle East Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. Middle East Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Africa Anavip Market
27.1. Africa Anavip Market Overview
27.2. Africa Anavip Market, Segmentation by Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Africa Anavip Market, Segmentation by Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.4. Africa Anavip Market, Segmentation by End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Anavip Market Competitive Landscape and Company Profiles
28.1. Anavip Market Competitive Landscape
28.2. Anavip Market Company Profiles
28.2.1. Rare Disease Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
29. Global Anavip Market Pipeline Analysis
29.1. High Level Clinic Trail Information
30. Global Anavip Market Competitive Benchmarking and Dashboard31. Key Mergers and Acquisitions in the Anavip Market32. Recent Developments in the Anavip Market
33. Anavip Market High Potential Countries, Segments and Strategies
33.1 Anavip Market in 2029 - Countries Offering Most New Opportunities
33.2 Anavip Market in 2029 - Segments Offering Most New Opportunities
33.3 Anavip Market in 2029 - Growth Strategies
33.3.1 Market Trend Based Strategies
33.3.2 Competitor Strategies
34. Appendix
34.1. Abbreviations
34.2. Currencies
34.3. Historic and Forecast Inflation Rates
34.4. Research Inquiries
34.5. About the Analyst
34.6. Copyright and Disclaimer

Executive Summary

Anavip Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on anavip market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Description

Where is the largest and fastest growing market for anavip? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anavip market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) by Indication: Neurotoxic; Cytotoxic; Hemotoxic; Cardiotoxic
2) by Distribution Channel: Direct Sales; Distributors
3) by End User: Hospitals; Clinics

Key Companies Mentioned: Rare Disease Therapeutics Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

  • Rare Disease Therapeutics Inc.